The purpose of this study was to evaluate the prevalence and impact of the I148M PNPLA3 polymorphism on the development of NAFLD and its progression to hepatic fibrosis in women with PCOS and to identify other possible risk factors associated with these outcomes. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.